Paul A. Grayson
CEO
Biotechnology
Bird Rock Bio
United States of America
Biography
Mr. Paul Grayson previously served as CEO of Fate Therapeutics (NASDAQ: FATE). Before this, he was managing director of Sanderling Ventures. Prior to Sanderling, Mr. Grayson served as the founding Chairman and CEO of Senomyx Inc. (NASDAQ: SNMX).
Research Interest
Biotechnology